Literature DB >> 33466379

Human Nails Permeation of an Antifungal Candidate Hydroalcoholic Extract from the Plant Sapindus saponaria L. Rich in Saponins.

Vanessa Mendes1, Flávia Franco Veiga1, Lidiane Vizioli de Castro-Hoshino2, Francielle Sato2, Mauro Luciano Baesso2, Beatriz Vesco1, Elton Cruz1, Izabel Cristina Piloto Ferreira3, Melyssa Negri1, Terezinha Inez Estivalet Svidzinski1.   

Abstract

We evaluated a hydroalcoholic extract of Sapindus saponaria L. pericarps (ETHOSS), as a candidate to a topical antifungal medicine for onychomycosis. ETHOSS was produced by extracting the crushed fruits in ethanol. The saponin contents were identified and characterized by electrospray ionization mass spectrometry. We measured the in vitro antifungal activity against three dermatophyte fungi, isolated from onychomycosis: Trichophyton rubrum, T. mentagrophytes, and T. interdigitale, using broth microdilution tests. The minimum fungicide concentration of ETHOSS ranged from 195.31 to 781.25 μg/mL. The cytotoxicity of the crude extract was tested on the HeLa cell line, and its ability to permeate into healthy human nails by photoacoustic spectroscopy and Fourier transformation infrared spectrometer (FTIR) spectroscopy by attenuated total reflection. Besides its strong antifungal activity, ETHOSS showed low cytotoxicity in human cells. It was able to permeate and reach the full thickness of the nail in one hour, without the aid of facilitating vehicles, and remained there for at least 24 h. These results suggest that ETHOSS has great potential for treating onychomycosis.

Entities:  

Keywords:  Sapindus saponaria L.; Trichophyton spp.; antifungal; human nail; onychomycosis; permeation

Mesh:

Substances:

Year:  2021        PMID: 33466379      PMCID: PMC7795084          DOI: 10.3390/molecules26010236

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  23 in total

1.  Fusarium oxysporum is an onychomycosis etiopathogenic agent.

Authors:  Flávia F Veiga; Lidiane V de Castro-Hoshino; Francielle Sato; Amanda Bombassaro; Vânia A Vicente; Vanessa Mendes; Mauro L Baesso; Melyssa Negri; Terezinha Ie Svidzinski
Journal:  Future Microbiol       Date:  2018-12-03       Impact factor: 3.165

Review 2.  Onychomycosis: Clinical overview and diagnosis.

Authors:  Shari R Lipner; Richard K Scher
Journal:  J Am Acad Dermatol       Date:  2018-06-28       Impact factor: 11.527

Review 3.  Onychomycosis: Treatment and prevention of recurrence.

Authors:  Shari R Lipner; Richard K Scher
Journal:  J Am Acad Dermatol       Date:  2018-06-28       Impact factor: 11.527

4.  The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' offices.

Authors:  A K Gupta; G Gupta; H C Jain; C W Lynde; K A Foley; D Daigle; E A Cooper; R C Summerbell
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-05-11       Impact factor: 6.166

Review 5.  Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.

Authors:  Sudhir Baswan; Gerald B Kasting; S Kevin Li; Randy Wickett; Brian Adams; Sean Eurich; Ryan Schamper
Journal:  Mycoses       Date:  2017-01-18       Impact factor: 4.377

6.  Anti-Candida activity of Brazilian medicinal plants.

Authors:  Marta Cristina Teixeira Duarte; Glyn Mara Figueira; Adilson Sartoratto; Vera Lúcia Garcia Rehder; Camila Delarmelina
Journal:  J Ethnopharmacol       Date:  2005-01-05       Impact factor: 4.360

Review 7.  A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.

Authors:  Aditya K Gupta; Sarah G Versteeg; Neil H Shear; Vincent Piguet; Antonella Tosti; Bianca Maria Piraccini
Journal:  Am J Clin Dermatol       Date:  2019-02       Impact factor: 7.403

8.  In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.

Authors:  Edílson Damke; Joyce K Tsuzuki; Diógenes A G Cortez; Izabel C P Ferreira; Thâmara A Bertoni; Márcia R Batista; Lucélia Donati; Terezinha I E Svidzinski; Márcia E L Consolaro
Journal:  BMC Complement Altern Med       Date:  2011-05-04       Impact factor: 3.659

9.  Propolis Is an Efficient Fungicide and Inhibitor of Biofilm Production by Vaginal Candida albicans.

Authors:  Isis Regina Grenier Capoci; Patrícia de Souza Bonfim-Mendonça; Glaucia Sayuri Arita; Raphaela Regina de Araújo Pereira; Marcia Edilaine Lopes Consolaro; Marcos Luciano Bruschi; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

10.  Phytochemical Characterization of Terminalia catappa Linn. Extracts and Their antifungal Activities against Candida spp.

Authors:  Analucia G Terças; Andrea de Souza Monteiro; Eduardo B Moffa; Julliana R A Dos Santos; Eduardo M de Sousa; Anna R B Pinto; Paola C da Silva Costa; Antonio C R Borges; Luce M B Torres; Allan K D Barros Filho; Elizabeth S Fernandes; Cristina de Andrade Monteiro
Journal:  Front Microbiol       Date:  2017-04-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.